|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
11-20-2008, 07:16 PM
|
|||
|
|||
Invitrogen Launches In Vivo RNAi Delivery Reagent - Products To Simplify And Enable R
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of its Invivofectamine? delivery reagent which enables short interference ribonucleic acid (siRNA) experiments in vivo.
You must register in order to see the links 
|
|
| Thread Tools | |
| Display Modes | |
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Intravail(R) Drug Delivery Technology Provides Unmatched Non-Invasive Delivery Of An | Reber | General Health | 0 | 11-18-2008 12:43 PM |
| Invitrogen Launches Microarray To Study Non-Coding RNA | Reber | General Health | 0 | 11-08-2008 04:27 AM |
| New Nanoparticle-Based In Vivo Transfection Reagent Launched | Reber | General Health | 0 | 11-04-2008 01:40 PM |
| Altogen Biosystems Launches New Nanoparticle Based In Vivo Transfection Reagent | Reber | General Health | 0 | 11-04-2008 01:40 PM |
| Obagi Medical Products Launches SoluCLENZ Rx Gel, The Only Prescription Solubilized B | Reber | General Health | 0 | 08-13-2008 09:09 PM |
Linear Mode
